IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RONCA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.413
EU - Europa 5.589
AS - Asia 3.932
SA - Sud America 732
AF - Africa 85
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 18.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.268
PL - Polonia 2.550
CN - Cina 1.282
SG - Singapore 1.281
DE - Germania 667
UA - Ucraina 656
IT - Italia 602
BR - Brasile 599
HK - Hong Kong 485
VN - Vietnam 295
FI - Finlandia 242
GB - Regno Unito 208
RU - Federazione Russa 168
TR - Turchia 161
IE - Irlanda 136
IN - India 117
CA - Canada 80
FR - Francia 74
BD - Bangladesh 56
ID - Indonesia 55
SE - Svezia 51
AR - Argentina 50
NL - Olanda 40
CZ - Repubblica Ceca 39
ES - Italia 38
ZA - Sudafrica 38
JP - Giappone 35
MX - Messico 34
BE - Belgio 33
AT - Austria 22
EC - Ecuador 21
PK - Pakistan 20
IR - Iran 18
CL - Cile 16
IQ - Iraq 15
CO - Colombia 12
AU - Australia 11
AZ - Azerbaigian 11
CH - Svizzera 11
MA - Marocco 11
PE - Perù 11
TH - Thailandia 11
LT - Lituania 10
SA - Arabia Saudita 10
VE - Venezuela 10
EU - Europa 9
KR - Corea 9
UZ - Uzbekistan 9
LK - Sri Lanka 8
PH - Filippine 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
ET - Etiopia 7
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
MU - Mauritius 6
TN - Tunisia 6
TW - Taiwan 6
EG - Egitto 5
JO - Giordania 5
NO - Norvegia 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AW - Aruba 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
LV - Lettonia 3
NP - Nepal 3
CY - Cipro 2
GD - Grenada 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NZ - Nuova Zelanda 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
Totale 18.762
Salva come PNG Salva come JPEG
Città #
Warsaw 2.543
Fairfield 1.066
Ashburn 868
Woodbridge 670
Singapore 617
Jacksonville 495
Houston 480
Hong Kong 477
Cambridge 412
Seattle 411
Ann Arbor 348
Chandler 347
Wilmington 333
Beijing 312
Brescia 291
Princeton 237
Los Angeles 207
New York 188
Nanjing 152
Munich 147
Helsinki 135
Dublin 130
Istanbul 127
Dearborn 123
The Dalles 108
Dong Ket 90
Ho Chi Minh City 89
San Francisco 81
Dallas 78
Chicago 66
Shanghai 66
Buffalo 65
Des Moines 65
São Paulo 62
Moscow 58
Redondo Beach 54
Milan 50
Nanchang 48
Jakarta 47
Shenyang 46
Changsha 45
Hebei 40
San Diego 39
Hanoi 38
Phoenix 37
Jinan 36
Santa Clara 36
Lancaster 32
Brussels 31
London 31
Tianjin 31
Brooklyn 30
Montreal 30
Turku 30
Stockholm 29
Tokyo 29
Brno 27
Hangzhou 23
Denver 22
Frankfurt am Main 21
Johannesburg 21
Orem 21
Boardman 20
Kunming 19
Atlanta 18
Chennai 18
Guangzhou 18
Nuremberg 18
Boston 17
Rio de Janeiro 17
Belo Horizonte 16
Lappeenranta 16
Ningbo 16
Taizhou 16
Toronto 16
Rome 15
Verona 15
Washington 15
Porto Alegre 14
San Mateo 14
Falkenstein 13
Jiaxing 13
Haikou 12
Hefei 12
Baku 11
Charlotte 11
Dhaka 11
Düsseldorf 11
Poplar 11
Romola 11
Zhengzhou 11
Ankara 10
Brasília 10
Colombo 10
Nürnberg 10
Ottawa 10
Vienna 10
Amsterdam 9
Augusta 9
Campinas 9
Totale 13.380
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 322
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 303
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 297
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 283
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 275
Tumor angiogenesis revisited: Regulators and clinical implications 274
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 271
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 268
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 262
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 261
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 258
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 254
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 251
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 251
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 248
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 242
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 239
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 230
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 218
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 214
Stromal delivery of long Pentraxin-3 impairsFGF7FGFR-dependent tumor growth and metastasis 212
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 202
Long pentraxin-3 follows and modulates bladder cancer progression 196
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 195
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 194
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 191
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 183
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 183
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 181
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 180
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 178
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 174
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 170
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 170
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 169
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 167
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 165
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 163
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 163
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 162
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents 162
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 161
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 160
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 159
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 158
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 158
Beta-Galactosylceramidase deficiency: neurovascular implications 154
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 154
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 154
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 151
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 148
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 148
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 145
Long pentraxin 3: A novel multifaceted player in cancer 145
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 143
Circulating microRNAs and Their Role in Multiple Myeloma 143
Future applications of FGF/FGFR inhibitors in cancer 143
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 139
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 138
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies 137
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 135
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 133
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 132
Vascular disrupting activity of combretastatin analogues 130
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 129
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 129
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 129
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 128
Heparin derivatives as angiogenesis inhibitors 127
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 125
Ten Years of CRISPRing Cancers In Vitro 122
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 120
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 118
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 118
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 114
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 113
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 113
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 111
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 106
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 106
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 106
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 104
HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies 104
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 103
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 103
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 102
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 100
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 98
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 96
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells 96
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation 96
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 93
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 92
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 91
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 91
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 90
TR-764 is a novel tubulin binding agent with strong antiangiogenic activity. 90
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 89
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 87
LONG PENTRAXIN-3 INHIBITS FGF-DEPENDENT ANGIOGENESIS AND GROWTH OF STEROID HORMONE-REGULATED TUMORS 86
Totale 16.174
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.750
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.525 0 0 0 0 0 227 151 253 255 247 238 154
2021/20221.124 88 199 47 27 19 53 73 74 45 116 100 283
2022/20231.027 175 32 57 56 99 241 6 90 145 4 64 58
2023/20241.263 76 30 136 54 48 207 52 73 260 63 56 208
2024/20252.929 34 40 43 445 240 268 250 160 373 210 488 378
2025/20263.373 607 706 415 836 750 59 0 0 0 0 0 0
Totale 19.146